These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8002779

  • 1. Generation of multiple drug resistance by sequential in vitro passage of the human immunodeficiency virus type 1.
    Gao Q, Gu Z, Salomon H, Nagai K, Parniak MA, Wainberg MA.
    Arch Virol; 1994; 136(1-2):111-22. PubMed ID: 8002779
    [Abstract] [Full Text] [Related]

  • 2. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine.
    Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA.
    J Virol; 1992 Dec; 66(12):7128-35. PubMed ID: 1279198
    [Abstract] [Full Text] [Related]

  • 3. Generation of nucleoside-resistant variants of HIV-1 by in vitro selection in the presence of AZT or DDI but no by combinations.
    Gao Q, Parniak MA, Gu Z, Wainberg MA.
    Leukemia; 1992 Dec; 6 Suppl 3():192S-195S. PubMed ID: 1602823
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
    Gao Q, Gu Z, Hiscott J, Dionne G, Wainberg MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response of Ethiopian human immunodeficiency virus type 1 isolates to antiviral compounds.
    Wondimu Z, Sönnerborg A, Ayehunie S, Britton S, Strannegård O.
    Antiviral Res; 1992 Oct 01; 19(4):353-9. PubMed ID: 1281393
    [Abstract] [Full Text] [Related]

  • 9. In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
    Gao Q, Gu ZX, Parniak MA, Li XG, Wainberg MA.
    J Virol; 1992 Jan 01; 66(1):12-9. PubMed ID: 1727474
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Natural occurrence of drug resistance mutations in the reverse transcriptase of human immunodeficiency virus type 1 isolates.
    Nájera I, Richman DD, Olivares I, Rojas JM, Peinado MA, Perucho M, Nájera R, López-Galíndez C.
    AIDS Res Hum Retroviruses; 1994 Nov 01; 10(11):1479-88. PubMed ID: 7534096
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
    Gashnikova N, Plyasunova O, Kiseleva Y, Fedyuk N, Pokrovsky A.
    Nucleosides Nucleotides Nucleic Acids; 2003 Nov 01; 22(5-8):991-4. PubMed ID: 14565328
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE, Bridges EG, Liu SH, Gullen E, Guo X, Kukhanova M, Cheng YC.
    Antimicrob Agents Chemother; 1998 Jul 01; 42(7):1799-804. PubMed ID: 9661024
    [Abstract] [Full Text] [Related]

  • 18. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M, Kemp SD, Parry NR, Larder BA.
    Proc Natl Acad Sci U S A; 1993 Jun 15; 90(12):5653-6. PubMed ID: 7685907
    [Abstract] [Full Text] [Related]

  • 19. Evidence of a role for the Q151L mutation and the viral background in development of multiple dideoxynucleoside-resistant human immunodeficiency virus type 1.
    García-Lerma JG, Gerrish PJ, Wright AC, Qari SH, Heneine W.
    J Virol; 2000 Oct 15; 74(20):9339-46. PubMed ID: 11000201
    [Abstract] [Full Text] [Related]

  • 20. Loss of synergistic response to combinations containing AZT in AZT-resistant HIV-1.
    Cox SW, Albert J, Wahlberg J, Uhlén M, Wahren B.
    AIDS Res Hum Retroviruses; 1992 Jul 15; 8(7):1229-34. PubMed ID: 1520536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.